Navigation Links
New research says winning a Nobel Prize adds nearly 2 years to your lifespan

New research by the University of Warwick reveals that a Nobel Prize brings more than just cash and kudos - it can also add nearly two years to your life.

The research by Professor Andrew Oswald, an economist at the University of Warwick, and Matthew Rablen, (a former Warwick postgraduate researcher now a government economist), is published this month in a study entitled "Mortality and Immortality".

The researchers carried out their study in order to try to answer a long-standing question for economists and medical researchers as to whether social status alone can affect people's well being and lifespan. Although the existence of some kind of effect is known from studies of monkey packs, in humans it has been difficult up till now to separate any perceived positive effect of "status" from the effect of simple greater wealth that status often brings. Nobel Prize winners were viewed as an ideal group to study as the winners could be seen as having their status suddenly dropped on them. They also come with a ready made control group they can be directly measured against - scientists who were nominated for a Nobel prize but did not actually win one.

The researchers looked at winners and nominees in physics and chemistry between 1901 and 1950 (the full list of nominees are kept secret for 50 years). This gave them 528 male scientists with known biographical details (birth and death dates). They looked at one sex only to avoid differences in life span between sexes. They dropped four from that total who died prematurely for non biological reasons - such as active combat in the First World War. That left 524 scientists, of whom 135 actually won a Nobel Prize.

The average life span for this group was just over 76 years. Winners of the Nobel Prize were found to live 1.4 years longer on average (77.2 years) than those who had "merely" been nominated for a prize (who lived on average for 75.8 years). When the survey was restricted to only c
'"/>

Source:University of Warwick


Page: 1 2

Related biology news :

1. Columbia research lifts major hurdle to gene therapy for cancer
2. U of M researcher examines newly emerging deadly disease
3. NYU researchers simulate molecular biological clock
4. First atlas of key brain genes could speed research on cancer, neurological diseases
5. New research questions basic tenet of neuron function
6. Vital step in cellular migration described by UCSD medical researchers
7. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
8. UCSD researchers maintain stem cells without contaminated animal feeder layers
9. Why do insects stop breathing? To avoid damage from too much oxygen, say researchers
10. New protein discovered by Hebrew University researchers
11. First real-time view of developing neurons reveals surprises, say Stanford researchers

Post Your Comments:
(Date:11/6/2009)...h anniversary this month of the publication of On ...iological Sciences (AIBS) is publishing open acces...and his historic insights into evolution. , The t...of California, Berkeley, and James T. Costa of Wes...yths About Charles Darwin," appeared in the Octobe...
(Date:11/5/2009)...ion of Biology Teachers (NABT) will recognize Leon... at Naugatuck Valley Community College (NVCC) in W...cation Award during the NABT annual professional d...09 in Denver, Colorado. , The Evolution Educatio...f Biological Sciences,(AIBS) and Biological Scien...
(Date:11/4/2009)...n natural science) , United States Using Less ... today than it did 35 years ago, despite a 30 perc... partly attributable to alternative cooling method...stems. According to the latest USGS water use repo...ates goes to cooling thermoelectric power plants. ...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Cardiac stem cell trial seeks to treat some heart attack patients 58592 1Cardiac stem cell trial seeks to treat some heart attack patients 58592 2Cardiac stem cell trial seeks to treat some heart attack patients 58592 3Study explores how life experiences contribute to the biological changes of Alzheimers 10197 1Study explores how life experiences contribute to the biological changes of Alzheimers 10197 2Study explores how life experiences contribute to the biological changes of Alzheimers 10197 3FDA Approves PRE PEN Penicillin Allergy Test 58590 1FDA Approves PRE PEN Penicillin Allergy Test 58590 2
...ctedly from the ocean to rescue a dying coral reef...dramatic flair of comic-book superhero Batman, a b...d to death by seaweed ?although the fish was never...s at the ARC Centre of Excellence for Coral Reef S...are lost to weed were astonished when, after remov...
...tic increase in testicular cancer, now the most co...asian men, is the focus of a five-year, $5.5 milli...ublic Health researcher Tongzhang Zheng. , Testicu...his study will provide important information on po...rs,?said Zheng, professor and head of the Division...
...any of them had narrow, pointed teeth, which were ...ing them. But how did they then grind their food? ...they were helped by stones which they swallowed. I...d of ,gastric mill,. But this assumption does not ...ies of Bonn and Tübingen have now proved. Their re...
Other Biology News:Batfish to the rescue! 2Dinosaurs -- stones did not help with digestion 2Dinosaurs -- stones did not help with digestion 3
(Date:11/5/2009)...A, Neb., Nov. 5 Transgen...ced financial results for the quarter ended Septem...presented in the tables that follow. ,, Third ...s of $366,000 or $0.01 per share for the third qua... or $0.01 per share for the third quarter of 2008....
(Date:11/5/2009)...DIEGO, CA, November 5, 2009 /PRNewswire-FirstCall/...sed on using proprietary taste receptor-based tech...the food, beverage, and ingredient supply industri... financial results for the third quarter ended Sep...he third quarter of 2009, compared to $4.0 million...
(Date:11/5/2009)... Drug safety specialty firm BioSote... and Informatics earned the Certified Professional...ial from the American Society for Training and Dev... Flewell has more than fifteen years of medical co...nd is responsible for the development of the compa...
(Date:11/4/2009)... The Human Anthrax Vaccine Program ...pleted the feature film "A Call to Arms:2009 ...ary "Fatal Immunity: The Human Anthrax Vaccin... and present danger of top secret government scien...ith no accountability to its victims. It is avail...
Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7
... and Tragara Pharmaceuticals Inc. today announced ...se to Tragara to develop and commercialize its nov...terms of the agreement S*BIO is eligible to receiv...s an upfront fee, development and sales milestone ...onally, S*BIO will perform certain preclinical act...
... (Nasdaq: NLTX ), today announced that it will f...ic peptide franchise, including CD-NP which is in ...CU-NP which is a pre-clinical compound. Nile will ...urn license rights for the compound to Dr. Cesare ... unable to continue to pursue the development of 2...
...ex: DDD ) today announced that the U. S. Food an...Response letter for its Abbreviated New Drug Appli...n, filed by SCOLR on August 5, 2008, seeks approva...t based on its patented Controlled Delivery Techno...e letter requests additional information, all of w...
Other Biology Technology:S*BIO and Tragara Announce an Exclusive Worldwide License Agreement for Novel Multi-kinase Inhibitor SB1317 2S*BIO and Tragara Announce an Exclusive Worldwide License Agreement for Novel Multi-kinase Inhibitor SB1317 3Nile Therapeutics Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program 2Nile Therapeutics Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program 3Nile Therapeutics Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program 4FDA Issues Complete Response Letter to SCOLR Pharma's Abbreviated New Drug Application for CDT(R) 12-Hour Pseudoephedrine 2FDA Issues Complete Response Letter to SCOLR Pharma's Abbreviated New Drug Application for CDT(R) 12-Hour Pseudoephedrine 3
Custom siRNA, HPLC purified, annealed from Ambion
Silencer Pre-designed siRNA, standard purity from Ambion
Silencer Pre-designed siRNA, standard purity, annealed from Ambion
Silencer Pre-designed siRNA, HPLC purified, annealed from Ambion
Biology Products: